Abstract
Different imaging strategies have been developed targeting the peculiar features of neuroendocrine tumors (NETs). Metabolic characteristics and receptor expression on the tumor surface have been studied, and expertise and knowledge are increasing as a result of the implementation of fusion imaging and the development of more detailed positron emission tomography tracers. Scintigraphic study of NETs is the most diffused and convenient technique for evaluating patients suspected to have NETs.
Keywords:
Pentetreotide; Somatostatin; Somatostatin analogues; mIBG.
Copyright © 2014 Elsevier Inc. All rights reserved.
MeSH terms
-
3-Iodobenzylguanidine*
-
Adrenal Gland Neoplasms / diagnostic imaging
-
Carcinoma, Neuroendocrine
-
Contraindications
-
Humans
-
Intestinal Neoplasms / diagnostic imaging
-
Lung Neoplasms / diagnostic imaging
-
Neuroblastoma / diagnostic imaging
-
Neuroendocrine Tumors / diagnostic imaging*
-
Pancreatic Neoplasms / diagnostic imaging
-
Paraganglioma / diagnostic imaging
-
Pheochromocytoma / diagnostic imaging
-
Pituitary Neoplasms / diagnostic imaging
-
Radiopharmaceuticals*
-
Receptors, Somatostatin / metabolism
-
Somatostatin / analogs & derivatives*
-
Stomach Neoplasms / diagnostic imaging
-
Thyroid Neoplasms / diagnostic imaging
-
Tomography, Emission-Computed, Single-Photon / methods*
-
Tomography, Emission-Computed, Single-Photon / trends
Substances
-
Radiopharmaceuticals
-
Receptors, Somatostatin
-
3-Iodobenzylguanidine
-
Somatostatin
Supplementary concepts
-
Gastro-enteropancreatic neuroendocrine tumor
-
Thyroid cancer, medullary